Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: The EXCITE study
- Ursula Schmidt-Erfurth*
- , Bora Eldem
- , Robyn Guymer
- , Jean Franois Korobelnik
- , Reinier O. Schlingemann
- , Ruth Axer-Siegel
- , Peter Wiedemann
- , Christian Simader
- , Margarita Gekkieva
- , Andreas Weichselberger
*Corresponding author for this work
- University of Vienna
- Hacettepe University
- University of Melbourne
- Groupe hospitalier Pellegrin
- Academic Medical Centre
- Rabin Medical Center Israel
- Leipzig University
- Medical University of Vienna
- Novartis
Research output: Contribution to journal › Article › peer-review
375
Scopus
citations